Lawrence S Barak

3.1k total citations · 1 hit paper
40 papers, 2.5k citations indexed

About

Lawrence S Barak is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Cell Biology. According to data from OpenAlex, Lawrence S Barak has authored 40 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Molecular Biology, 19 papers in Cellular and Molecular Neuroscience and 6 papers in Cell Biology. Recurrent topics in Lawrence S Barak's work include Receptor Mechanisms and Signaling (23 papers), Neuropeptides and Animal Physiology (16 papers) and Neurotransmitter Receptor Influence on Behavior (4 papers). Lawrence S Barak is often cited by papers focused on Receptor Mechanisms and Signaling (23 papers), Neuropeptides and Animal Physiology (16 papers) and Neurotransmitter Receptor Influence on Behavior (4 papers). Lawrence S Barak collaborates with scholars based in United States, Germany and Japan. Lawrence S Barak's co-authors include Marc G. Caron, W. W. Webb, Eugene A. Nothnagel, R. Rogers Yocum, Stephen S. G. Ferguson, M G Caron, Lauren M. Slosky, Robert J. Lefkowitz, Neil J. Freedman and Madan M. Kwatra and has published in prestigious journals such as Nature, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Lawrence S Barak

36 papers receiving 2.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A highly conserved tyrosine residue in G protein-coupled receptors is required for agonist-mediated beta 2-adrenergic receptor sequestration.

1994 327 citations Lawrence S Barak, Marc G. Caron et al. profile →

Peers

Countries citing papers authored by Lawrence S Barak

Since Specialization

Citations

This map shows the geographic impact of Lawrence S Barak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lawrence S Barak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lawrence S Barak more than expected).

Fields of papers citing papers by Lawrence S Barak

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lawrence S Barak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lawrence S Barak. The network helps show where Lawrence S Barak may publish in the future.

Co-authorship network of co-authors of Lawrence S Barak

This figure shows the co-authorship network connecting the top 25 collaborators of Lawrence S Barak. A scholar is included among the top collaborators of Lawrence S Barak based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lawrence S Barak. Lawrence S Barak is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Designing allosteric modulators to change GPCR G protein subtype selectivity 2025 ·Nature ·(unknown), (unknown), (unknown), (unknown), (unknown), Nathan R. Foster, (unknown), Asuka Inoue, Michael R. Jackson, Michael J. Sheedlo, Lawrence S Barak, Ezequiel Marrón Fernández de Velasco, Steven H. Olson, Lauren M. Slosky	0
2	Nonlinear progression during the occult transition establishes cancer lethality 2025 ·Disease Models & Mechanisms ·(unknown), Henry N. Chapman, (unknown), (unknown), Lawrence S Barak, Robert D. Cardiff, Alexander D. Borowsky, H. Kim Lyerly, Bruce Rogers, Joshua C. Snyder	0
3	Neurotensin Receptor Allosterism Revealed in Complex with a Biased Allosteric Modulator 2023 ·Biochemistry ·B. Krumm, Jeffrey F. DiBerto, Reid H. J. Olsen, Hye Jin Kang, Samuel T. Slocum, Shicheng Zhang, Ryan T. Strachan, Xi‐Ping Huang, Lauren M. Slosky, Anthony B. Pinkerton, Lawrence S Barak, Marc G. Caron, Terry Kenakin, Jonathan F. Fay, Bryan L. Roth	36
4	Neurotensin receptor 1-biased ligand attenuates neurotensin-mediated excitation of ventral tegmental area dopamine neurons and dopamine release in the nucleus accumbens 2023 ·Neuropharmacology ·(unknown), Vivien Zell, Lauren Faget, Lauren M. Slosky, Lawrence S Barak, Marc G. Caron, Anthony B. Pinkerton, Thomas S. Hnasko	6
5	Ghrelin receptor signaling in health and disease: a biased view 2022 ·Trends in Endocrinology and Metabolism ·Joshua Gross, Yang Zhou, Lawrence S Barak, Marc G. Caron	17
6	Discovery of a functionally selective ghrelin receptor (GHSR _1a ) ligand for modulating brain dopamine 2022 ·Proceedings of the National Academy of Sciences ·Joshua Gross, (unknown), Yang Zhou, Daniel J. Jansen, Lauren M. Slosky, (unknown), (unknown), Xin Hu, Noel Southall, (unknown), Xin Xu, Elena Barnaeva, William C. Wetsel, Marc Ferrer, Juan Marugán, Marc G. Caron, Lawrence S Barak, Krisztián Tóth	10
7	Establishment of multi-stage intravenous self-administration paradigms in mice 2022 ·Scientific Reports ·Lauren M. Slosky, (unknown), Yushi Bai, (unknown), Elizabeth R. Hauser, Joshua Gross, (unknown), Yang Zhou, Xiaoxiao Chen, Vladimir M. Pogorelov, Krisztián Tóth, William C. Wetsel, Lawrence S Barak, Marc G. Caron	9
8	HER2 Isoforms Uniquely Program Intratumor Heterogeneity and Predetermine Breast Cancer Trajectories During the Occult Tumorigenic Phase 2021 ·Molecular Cancer Research ·(unknown), Chaitanya R. Acharya, Veronica Lubkov, Hidetoshi Mori, (unknown), Lauren K. Rochelle, Wendy L. Roberts, Jeffrey I. Everitt, Zachary C. Hartman, Erika J. Crosby, Lawrence S Barak, Marc G. Caron, (unknown), Neil E. Hubbard, Robert D. Cardiff, Alexander D. Borowsky, H. Kim Lyerly, Joshua C. Snyder	11
9	Biased Allosteric Modulators: New Frontiers in GPCR Drug Discovery 2021 ·Trends in Pharmacological Sciences ·Lauren M. Slosky, Marc G. Caron, Lawrence S Barak	132
10	β-Arrestin-Biased Allosteric Modulator of NTSR1 Selectively Attenuates Addictive Behaviors 2020 ·Cell ·Lauren M. Slosky, Yushi Bai, Krisztián Tóth, (unknown), Lauren K. Rochelle, Alexandra Badea, Rahul Chandrasekhar, Vladimir M. Pogorelov, Dennis Abraham, (unknown), Satyamaheshwar Peddibhotla, Michael P. Hedrick, Paul Hershberger, Patrick Maloney, Hong Yuan, Zibo Li, William C. Wetsel, Anthony B. Pinkerton, Lawrence S Barak, Marc G. Caron	94
11	PCM1 is necessary for focal ciliary integrity and is a candidate for severe schizophrenia 2020 ·Nature Communications ·Tanner O. Monroe, Melanie E. Garrett, Maria Kousi, Ramona M. Rodriguiz, Sungjin Moon, Yushi Bai, (unknown), Karen Soldano, Jeremiah Savage, Thomas Folkmann Hansen, Donna M. Muzny, Richard A. Gibbs, Lawrence S Barak, Patrick F. Sullivan, Allison E. Ashley‐Koch, Akira Sawa, William C. Wetsel, Thomas Werge, Nicholas Katsanis	19
12	Discovery of β-Arrestin Biased, Orally Bioavailable, and CNS Penetrant Neurotensin Receptor 1 (NTR1) Allosteric Modulators 2019 ·Journal of Medicinal Chemistry ·Anthony B. Pinkerton, Satyamaheshwar Peddibhotla, (unknown), Lauren M. Slosky, Yushi Bai, Patrick Maloney, Paul Hershberger, Michael P. Hedrick, (unknown), Robert Ardecky, Layton H. Smith, Thomas D.Y. Chung, Michael R. Jackson, Marc G. Caron, Lawrence S Barak	32
13	A Brief History of the β-Arrestins 2019 ·Methods in molecular biology ·Marc G. Caron, Lawrence S Barak	16
14	Ghrelin receptor antagonism of hyperlocomotion in cocaine‐sensitized mice requires βarrestin‐2 2017 ·Synapse ·Krisztián Tóth, Lauren M. Slosky, Thomas F. Pack, Nikhil M. Urs, (unknown), Lan Mao, Dennis Abraham, Marc G. Caron, Lawrence S Barak	13
15	Imidazole-derived agonists for the neurotensin 1 receptor 2013 ·Bioorganic & Medicinal Chemistry Letters ·Paul Hershberger, Michael P. Hedrick, Satyamaheshwar Peddibhotla, Arianna Mangravita-Novo, (unknown), Yujie Li, (unknown), Michael Vicchiarelli, Layton H. Smith, Thomas D.Y. Chung, James B. Thomas, Marc G. Caron, Anthony B. Pinkerton, Lawrence S Barak, Gregory P. Roth	14
16	Selective KOP Receptor Antagonists: Probe 1 2010 ·Michael P. Hedrick, (unknown), Kevin J. Frankowski, David A. Whipple, Shenghua Shi, Thomas E. Prisinzano, Frank J. Schoenen, Jeffrey Aubé, (unknown), (unknown), Eduard Sergienko, (unknown), Santosh Hariharan, (unknown), Susanne Heynen‐Genel, Thomas D.Y. Chung, (unknown), Marc G. Caron, Laura Bohn, Lawrence S Barak	0
17	Regulation of M₂‐type pyruvate kinase mediated by the high‐affinity IgE receptors is required for mast cell degranulation 2008 ·British Journal of Pharmacology ·Hyang‐Hwa Ryu, Julia K. L. Walker, (unknown), (unknown), Lawrence S Barak, Takuya Noguchi, (unknown), (unknown)	26
18	G-protein-coupled receptor regulation: role of G-protein-coupled receptor kinases and arrestins 1996 ·Canadian Journal of Physiology and Pharmacology ·Stephen S. G. Ferguson, Lawrence S Barak, (unknown), M G Caron	293
19	Differential staining of actin in metaphase spindles with 7-nitrobenz-2-oxa-1,3-diazole-phallacidin and fluorescent DNase: is actin involved in chromosomal movement? 1981 ·Proceedings of the National Academy of Sciences ·Lawrence S Barak, Eugene A. Nothnagel, (unknown), W. W. Webb	55
20	Fluorescence staining of the actin cytoskeleton in living cells with 7-nitrobenz-2-oxa-1,3-diazole-phallacidin. 1980 ·Proceedings of the National Academy of Sciences ·Lawrence S Barak, R. Rogers Yocum, Eugene A. Nothnagel, W. W. Webb	406

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact